Low-Flow Aortic Stenosis: What is the Value of Valve Calcification in its Interpretation?

Delays in the treatment of symptomatic aortic stenosis (AS) reduce prognosis, especially in elderly patients. Accurate assessment of AS severity is crucial to avoid overtreatment and its associated risks. A transthoracic echocardiogram (TTE) is the initial evaluation in the diagnostic algorithm, and severity values are well established. However, some patients may obtain discordant data due to low flow, masking true severity.

Estenosis aórtica pura vs mixta en TAVI: beneficios y evolución

Dobutamine stress echocardiography (DSE) corrects the effect of low flow, allowing for the adequate assessment of the aortic valve area (AVA) and mean transvalvular gradient. Computed tomography (CT) can quantify aortic valve calcification (AVC), estimating severity when it exceeds a threshold of ≥2000 AU in men and ≥1200 AU in women.

The objective of this study was to assess the discrimination power of CT regarding the detection of severe aortic stenosis, as assessed by TTE and DSE, in patients with low-flow, low-gradient AS. Additionally, it assessed whether CT could replace DSE in patients with low-gradient AS.

Researchers conducted a multicenter observational study that included 271 patients with AS who underwent DSE to assess severity and CT for AVC scoring. Discordant AS was defined as AVA ≤1 cm², peak velocity ≤4 m/s, and gradient ≤40 mmHg, with a stroke volume index (SVi) <35 mL/m² in women or <40 mL/m² in men.

Read also: Long Term Outcomes of Hyperemic Stenosis Resistance Index (HSR) in Patients with Stable Chronic Angina.

Data obtained came from 214 patients (main cohort) from 8 centers in Europe and the US. Severe AS was diagnosed in 49.5% of cases and moderate AS in 50.5% (only in 4.7% of patients with deteriorated ventricular function their AVA increased to >1.0 cm², confirming moderate AS). The average age was 78 years, with a body surface area of 1.9 m²; 76.1% of patients were men, 92.1% had an ejection fraction <50%, and 9.3% had bicuspid valve morphology.

When assessing AVC, 44.3% of patients with severe AS exceeded 2000 AU (men) and 1200 AU (women) in the Agatston score, compared with 43.5% of patients with moderate AS who exceeded these cut-off points. This corresponds to a sensitivity of 44.3%, a specificity of 56.5%, a positive predictive value (PPV) of 50%, and a negative predictive value (NPV) of 50.8% for the AU cut-off in identifying AS severity. On average, 51.7% of patients were correctly classified using the AVC score.

When assessed by sex, only 50.9% of men were correctly classified using AVC, with a PPV of 45.3% and an NPV of 55.7%. Regarding women, the rate for correct classification based on calcification was 49%. The area under the curve was 0.508 (95% confidence interval [CI]: 0.418-0.597) for men and 0.524 for women.

Read also: BIONYX: Onyx vs. Orsiro At 5 Years.

The survival time for moderate AS was 5.1 years and for severe AS was 4.1 years. When evaluating all-cause mortality, patients with greater severity experienced more events (hazard ratio [HR]: 1.46; 95% CI: 0.93-2.3; P = 0.099), as well as a higher rate of cardiovascular death (HR: 1.26; 95% CI: 0.80-2.0; P = 0.339).

Conclusions

The use of the valve calcification scores obtained through CT showed poor discriminatory capacity between grades of severity according to DSE. These results indicate that AVC cannot replace DSE in the diagnostic algorithm for patients with low-flow severe AS.

Dr. Omar Tupayachi

Dr. Omar Tupayachi.
Member of the Editorial Board of SOLACI.org.

Original Title: Diagnostic Value of Aortic Valve Calcification Levels in the Assessment of Low-Gradient Aortic Stenosis.

Reference: Adrichem, R, Hokken, T, Bouwmeester, S. et al. Diagnostic Value of Aortic Valve Calcification Levels in the Assessment of Low-Gradient Aortic Stenosis. J Am Coll Cardiol Img. null2024, 0 (0). https://doi.org/10.1016/j.jcmg.2024.03.014.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....